2 diabetes: a parallel-group study. Lancet 359:824–830, 2002 33. Turner RC, Cull CA, Frighi V, Holman RR, UKPDS Group: Glycemic controlwith diet, sulfonylurea, metformin, or in-sulin in patients with type 2 diabetes mel-litus. Progressive requirement for multipletherapies (UKPDS 49). JAMA 281:2005– 2012, 1999 34. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effectof excessive weight gain with intensivetherapy of type 1 diabetes on lipid levelsand blood pressure: results from theDCCT. JAMA 280:140–146, 1998 35. Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, BloomSR: Exendin-4: reduces fasting and post-prandial glucose and decreases energy in- Exendin-4 (AC2993) and glycemic control 2376 DIABETES CARE,VOLUME 26, NUMBER 8, A UGUST 2003Downloaded from http://diabetesjournals.org/care/article-pdf/26/8/2370/660914/dc08030023 0.pdf by guest on 17 January 2024